Bio Green Med Solution (BGMS) Research & Development (2010 - 2025)

Bio Green Med Solution (BGMS) has reported Research & Development for 16 consecutive years, with -$47000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Research & Development fell 105.34% year-over-year to -$47000.0; the TTM figure through Dec 2025 stood at $848000.0 (down 87.26% YoY), while the FY2025 annual figure was $848000.0, down 87.26% from the prior year.
• Research & Development declined to -$47000.0 in Q4 2025 per BGMS's latest filing, from $5000.0 in the prior quarter.
• Across five years, Research & Development topped out at $6.7 million in Q4 2022 and bottomed at -$47000.0 in Q4 2025.
• Historically, Research & Development has averaged $3.1 million across 5 years, with a median of $3.7 million in 2021.
• Annual changes were most pronounced in 2021 — Research & Development surged 264.93% — and 2025, when it slumped 105.34%.
• Bio Green Med Solution's Research & Development stood at $4.3 million in 2021, then surged by 54.5% to $6.7 million in 2022, then tumbled by 47.51% to $3.5 million in 2023, then tumbled by 74.99% to $880000.0 in 2024, then sank by 105.34% to -$47000.0 in 2025.
• Business Quant data shows BGMS's Research & Development at -$47000.0 in Q4 2025, $5000.0 in Q3 2025, and $68000.0 in Q2 2025.